TANJA JOHNSON: Open Payments
NPI 1447654827 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,921 in 59 payments from 11 companies in 2025. Trend: 2023 $100 · 2024 $1,238 · 2025 $1,921
Food & beverage: $1,802Education: $119
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $559 |
| Supernus Pharmaceuticals, Inc. | 17 | $365 |
| Teva Pharmaceuticals USA, Inc. | 6 | $325 |
| Alkermes, Inc. | 5 | $308 |
| E.R. Squibb & Sons, L.L.C. | 4 | $188 |
| Otsuka America Pharmaceutical, Inc. | 3 | $54 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $41 |
| Vertical Pharmaceuticals, LLC | 1 | $26 |
| Axsome Therapeutics, Inc. | 1 | $25 |
| Janssen Pharmaceuticals, Inc | 1 | $16 |
Products named: VRAYLAR, Qelbree, LYBALVI, UZEDY, COBENFY, ARISTADA, REXULTI, CAPLYTA.
Industry payments across MO — which companies pay providers there.
